Epidemiology and etiology of Parkinson’s disease: a review of the evidence

[1]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[2]  P. Deyn,et al.  GIGYF2 has no major role in Parkinson genetic etiology in a Belgian population , 2011, Neurobiology of Aging.

[3]  Jie Wu,et al.  Parkinson’s disease in China , 2011, Neurological Sciences.

[4]  M. Silber,et al.  REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century , 2010, Neurology.

[5]  L. Wilkins,et al.  Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus , 2010, Neurology.

[6]  M. Farrer,et al.  α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease , 2010, Neuroepidemiology.

[7]  P. Knekt,et al.  Serum vitamin D and the risk of Parkinson disease. , 2010, Archives of neurology.

[8]  B. Ritz,et al.  Familial associations of Alzheimer disease and essential tremor with Parkinson disease , 2010, European journal of neurology.

[9]  Hidenao Fukuyama,et al.  Dietary glycemic index is inversely associated with the risk of Parkinson's disease: a case-control study in Japan. , 2010, Nutrition.

[10]  A. Reunanen,et al.  Persistent organochlorine pesticides in serum and risk of Parkinson disease , 2010, Neurology.

[11]  J. Gagne,et al.  Anti-inflammatory drugs and risk of Parkinson disease , 2010, Neurology.

[12]  R. Mailman,et al.  Smoking duration, intensity, and risk of Parkinson disease , 2010, Neurology.

[13]  S. Johansson,et al.  Cancer risk in association with Parkinson disease: a population-based study. , 2010, Parkinsonism & related disorders.

[14]  L. Forsgren,et al.  Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population‐based study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[15]  W. Oertel,et al.  Incidence of Parkinson's disease and atypical parkinsonism: Russian population‐based study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[16]  E. Schernhammer,et al.  Parkinson’s disease and cancer risk: a systematic review and meta-analysis , 2010, Cancer Causes & Control.

[17]  H. Checkoway,et al.  Occupational factors and risk of Parkinson's disease: A population-based case-control study. , 2009, American journal of industrial medicine.

[18]  N. Mateva,et al.  Incidence of Parkinson’s Disease in Bulgaria , 2009, Neuroepidemiology.

[19]  H. Berendse,et al.  Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[21]  C. Tanner,et al.  Urate as a predictor of the rate of clinical decline in Parkinson disease. , 2009, Archives of neurology.

[22]  R. Marconi,et al.  GIGYF2 mutations are not a frequent cause of familial Parkinson's disease. , 2009, Parkinsonism & related disorders.

[23]  Giuseppe Salemi,et al.  Diabetes preceding Parkinson's disease onset. A case-control study. , 2009, Parkinsonism & related disorders.

[24]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[25]  M. Nalls,et al.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.

[26]  A. Ascherio,et al.  Family history of melanoma and Parkinson disease risk , 2009, Neurology.

[27]  C. Tzourio,et al.  Professional exposure to pesticides and Parkinson disease , 2009, Annals of neurology.

[28]  Connie Marras,et al.  Occupation and risk of parkinsonism: a multicenter case-control study. , 2009, Archives of neurology.

[29]  E. Okello,et al.  Combined statin/coenzyme Q10 as adjunctive treatment of chronic heart failure. , 2009, Medical hypotheses.

[30]  A. Winogrodzka,et al.  Parkinson's disease, levodopa-use and the risk of melanoma. , 2009, Parkinsonism & related disorders.

[31]  E. Skjerve,et al.  Levels of chlorinated pesticides and polychlorinated biphenyls in Norwegian breast milk (2002-2006), and factors that may predict the level of contamination. , 2009, The Science of the total environment.

[32]  B. Ritz,et al.  Well-Water Consumption and Parkinson’s Disease in Rural California , 2009, Environmental health perspectives.

[33]  J. Perlmutter,et al.  A Population-Based Study of Parkinsonism in an Amish Community , 2009, Neuroepidemiology.

[34]  Honglei Chen,et al.  Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[35]  D. Maraganore,et al.  Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study. , 2009, Parkinsonism & related disorders.

[36]  T. Foroud,et al.  Variation in GIGYF2 is not associated with Parkinson disease , 2009, Neurology.

[37]  C. Meier,et al.  Statins and the risk of Parkinson disease: an update on the controversy , 2009 .

[38]  W. Poewe,et al.  Mortality in Parkinson's disease: A 20‐year follow‐up study , 2009, Movement disorders : official journal of the Movement Disorder Society.

[39]  A. Brice,et al.  Parkinson's disease: from monogenic forms to genetic susceptibility factors. , 2009, Human molecular genetics.

[40]  M. Vendette,et al.  Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder , 2009, Neurology.

[41]  M. Stampfer.  Welding Occupations and Mortality from Parkinson's Disease and Other Neurodegenerative Diseases Among United States Men, 1985–1999 , 2009, Journal of occupational and environmental hygiene.

[42]  Honglei Chen,et al.  Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. , 2009, American journal of epidemiology.

[43]  E. H. Hernández.  Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies , 2009 .

[44]  G. Logroscino,et al.  Incidence and remaining lifetime risk of Parkinson disease in advanced age , 2009, Neurology.

[45]  V. Uversky,et al.  Smoking and Parkinson's disease: does nicotine affect alpha-synuclein fibrillation? , 2009, Biochimica et biophysica acta.

[46]  P. Aridon,et al.  Parkinson's Disease and Cancer , 2009, Annals of the New York Academy of Sciences.

[47]  W. Oyen,et al.  FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome , 2009, Neurology.

[48]  Jiali Han,et al.  Genetic determinants of hair color and parkinson's disease risk , 2009, Annals of neurology.

[49]  J. Olsen,et al.  Risk of Parkinson’s disease after hospital contact for head injury: population based case-control study , 2008, BMJ : British Medical Journal.

[50]  J. Benito-León,et al.  Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[51]  N. Pedersen,et al.  Complete ascertainment of Parkinson disease in the Swedish Twin Registry , 2008, Neurobiology of Aging.

[52]  E. Tan,et al.  Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore , 2008, Neurology.

[53]  J. Kopec,et al.  Gout and the risk of Parkinson's disease: a cohort study. , 2008, Arthritis and rheumatism.

[54]  R. Hauser,et al.  Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations , 2008, Movement disorders : official journal of the Movement Disorder Society.

[55]  A. Singleton,et al.  Analysis of Nigerians with Apparently Sporadic Parkinson Disease for Mutations in LRRK2, PRKN and ATXN3 , 2008, PloS one.

[56]  A. Singleton,et al.  Lack of replication of association between GIGYF2 variants and Parkinson disease. , 2008, Human molecular genetics.

[57]  M. Delong,et al.  Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. , 2008, Archives of neurology.

[58]  M. Hallett,et al.  The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. , 2008, Archives of neurology.

[59]  J. Buring,et al.  Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease , 2008, Diabetes Care.

[60]  S. Johansson,et al.  Diabetes in Patients With Idiopathic Parkinson's Disease , 2008, Diabetes Care.

[61]  A. Singleton,et al.  Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007 , 2008, Environmental health perspectives.

[62]  P. Grandjean,et al.  Prevalence and incidence of Parkinson’s disease in The Faroe Islands , 2008, Acta neurologica Scandinavica.

[63]  A. Ascherio,et al.  Variations in gender ratios support the connection between smoking and Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[64]  M. Mazzola,et al.  Body mass index does not change before Parkinson’s disease onset , 2008, European journal of neurology.

[65]  E. Budtz-Jørgensen,et al.  Impact of dietary exposure to food contaminants on the risk of Parkinson's disease. , 2008, Neurotoxicology.

[66]  E. Tolosa,et al.  Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study , 2008, The Lancet Neurology.

[67]  A. Reunanen,et al.  Prospective study of coffee consumption and risk of Parkinson's disease , 2008, European Journal of Clinical Nutrition.

[68]  M. Shardell,et al.  Parkinson's disease and functional decline in older Mexican Americans. , 2008, Parkinsonism & related disorders.

[69]  Christine Klein,et al.  Replication of association between ELAVL4 and Parkinson disease: the GenePD study , 2008, Human Genetics.

[70]  J. Levin,et al.  Pesticide/Environmental Exposures and Parkinson's Disease in East Texas , 2008, Journal of agromedicine.

[71]  D. Hernandez,et al.  Characterization of PLA2G6 as a locus for dystonia‐parkinsonism , 2008, Annals of neurology.

[72]  A. Ascherio,et al.  Familial aggregation of Parkinson's disease: A meta‐analysis , 2008, Movement disorders : official journal of the Movement Disorder Society.

[73]  A. Lang,et al.  Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. , 2008, Archives of neurology.

[74]  M. Ronaghi,et al.  Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. , 2008, American journal of human genetics.

[75]  M. Stacy,et al.  A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease , 2008, Neurology.

[76]  G. Miller,et al.  Parkinson's disease and pesticides: a toxicological perspective. , 2008, Trends in pharmacological sciences.

[77]  M. Farrer,et al.  Genomic investigation of α‐synuclein multiplication and parkinsonism , 2008, Annals of neurology.

[78]  M. Kivipelto,et al.  Total cholesterol and the risk of Parkinson disease , 2008, Neurology.

[79]  Xuemei Huang,et al.  Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu‐Asia Aging Study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[80]  G. Logroscino,et al.  Parkinson disease and risk of mortality , 2008, Neurology.

[81]  N. Hattori,et al.  PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE , 2008, Neurology.

[82]  M. Farrer,et al.  &agr;-Synuclein, pesticides, and Parkinson disease: A case–control studySYMBOL , 2008, Neurology.

[83]  C. Lautier,et al.  Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. , 2008, American journal of human genetics.

[84]  A. Singleton,et al.  Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls , 2008, Human mutation.

[85]  Eden R Martin,et al.  Pesticide exposure and risk of Parkinson's disease: A family-based case-control study , 2008, BMC neurology.

[86]  P. Tuite,et al.  Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) , 2008, Annals of neurology.

[87]  C. Tanner,et al.  Association of olfactory dysfunction with risk for future Parkinson's disease , 2008, Annals of neurology.

[88]  Colin C. McCulloch,et al.  Exploring gene-environment interactions in Parkinson’s disease , 2008, Human Genetics.

[89]  L. Melton,et al.  Increased risk of parkinsonism in women who underwent oophorectomy before menopause , 2008, Neurology.

[90]  Michael J Thun,et al.  Recreational physical activity and risk of Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[91]  J. Nutt,et al.  Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk , 2008, Movement disorders : official journal of the Movement Disorder Society.

[92]  B. Jeon,et al.  α-Synuclein gene duplication is present in sporadic Parkinson disease , 2008, Neurology.

[93]  Jian-Min Yuan,et al.  Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study. , 2007, American journal of epidemiology.

[94]  D. Maraganore,et al.  Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. , 2007, Archives of general psychiatry.

[95]  J. J. Wang,et al.  Population prevalence and incidence of Parkinson’s disease in an Australian community , 2007, Internal medicine journal.

[96]  A. Elbaz,et al.  Epidemiologic studies of environmental exposures in Parkinson's disease , 2007, Journal of the Neurological Sciences.

[97]  Gang Hu,et al.  Coffee and tea consumption and the risk of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[98]  R. Paffenbarger,et al.  Body mass index and risk of Parkinson's disease: a prospective cohort study. , 2007, American journal of epidemiology.

[99]  Honglei Chen,et al.  Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease , 2007, Neurology.

[100]  Rivka Inzelberg,et al.  Are Parkinson disease patients protected from some but not all cancers? , 2007, Neurology.

[101]  D. Schaid,et al.  Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. , 2007, Archives of neurology.

[102]  Honglei Chen,et al.  Peripheral inflammatory biomarkers and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[103]  A. Hofman,et al.  Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease , 2007, Neuroepidemiology.

[104]  A. Levey,et al.  Evidence of shared risk for Alzheimer’s disease and Parkinson’s disease using family history , 2007, Neurogenetics.

[105]  M. Weisskopf,et al.  Plasma urate and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[106]  A. Dürr,et al.  Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls , 2007, Journal of Medical Genetics.

[107]  D. Schaid,et al.  Increased risk of essential tremor in first‐degree relatives of patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[108]  J. A. Cook,et al.  Heterogeneity in male to female risk for Parkinson’s disease , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[109]  K. Marder,et al.  Pooled analysis of tobacco use and risk of Parkinson disease. , 2007, Archives of neurology.

[110]  A. Lang,et al.  Deciphering the role of heterozygous mutations in genes associated with parkinsonism , 2007, The Lancet Neurology.

[111]  Michael Jerrett,et al.  A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. , 2007, Environmental research.

[112]  K. Murros,et al.  Low plasma uric acid level in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[113]  J. Buring,et al.  Prospective case–control study of nonfatal cancer preceding the diagnosis of parkinson’s disease , 2007, Cancer Causes & Control.

[114]  J. Buring,et al.  A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease , 2007, Cancer Epidemiology Biomarkers & Prevention.

[115]  E. Esposito,et al.  Non-steroidal anti-inflammatory drugs in Parkinson's disease , 2007, Experimental Neurology.

[116]  S. Rosso,et al.  Parkinson's Disease and Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[117]  R. Marconi,et al.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease , 2007, Neurology.

[118]  Michael J Thun,et al.  Consumption of dairy products and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[119]  Nir Giladi,et al.  The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. , 2007, Parkinsonism & related disorders.

[120]  N. Scott,et al.  Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study , 2007, Occupational and Environmental Medicine.

[121]  Kevin R. Sanft,et al.  Number of children and risk of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[122]  Dean P. Jones,et al.  Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system , 2007, Experimental Neurology.

[123]  W. Scott,et al.  Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. , 2007, Archives of neurology.

[124]  Anette Schrag,et al.  Estimated life expectancy of Parkinson’s patients compared with the UK population , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[125]  M. Farrer,et al.  Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication , 2007, Neurology.

[126]  M. Farrer,et al.  ELAVL4, PARK10, and the Celts , 2007, Movement disorders : official journal of the Movement Disorder Society.

[127]  M. Thun,et al.  Temporal relationship between cigarette smoking and risk of Parkinson disease , 2007, Neurology.

[128]  J. Jankovic,et al.  Exploring the relationship between essential tremor and Parkinson's disease. , 2007, Parkinsonism & related disorders.

[129]  Richard W. Murrow,et al.  Lower low‐density lipoprotein cholesterol levels are associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[130]  N. Venketasubramanian,et al.  Incidence of Parkinson's disease in Singapore. , 2007, Parkinsonism & related disorders.

[131]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[132]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[133]  N. Scott,et al.  Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study , 2007, Occupational and Environmental Medicine.

[134]  G Hu,et al.  Body mass index and the risk of Parkinson disease , 2006, Neurology.

[135]  D. Maraganore,et al.  Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies , 2006, Movement disorders : official journal of the Movement Disorder Society.

[136]  A. Blair,et al.  Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. , 2006, American journal of epidemiology.

[137]  Albert Hofman,et al.  Serum cholesterol levels and the risk of Parkinson's disease. , 2006, American journal of epidemiology.

[138]  K. Fuxe,et al.  Targeting adenosine A2A receptors in Parkinson's disease , 2006, Trends in Neurosciences.

[139]  Kevin R. Sanft,et al.  Chemical exposures and Parkinson's disease: A population‐based case–control study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[140]  G. Marsh,et al.  Employment as a Welder and Parkinson Disease Among Heavy Equipment Manufacturing Workers , 2006, Journal of occupational and environmental medicine.

[141]  J. Trojanowski,et al.  Glucocerebrosidase mutations are an important risk factor for Lewy body disorders , 2006, Neurology.

[142]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[143]  J. Olsen,et al.  Malignant Melanoma and Other Types of Cancer Preceding Parkinson Disease , 2006, Epidemiology.

[144]  K. Hemminki,et al.  Familial risks of hospitalization for Parkinson’s disease in first-degree relatives: a nationwide follow-up study from Sweden , 2006, Neurogenetics.

[145]  R. Paffenbarger,et al.  Physical activity and risk of Parkinson’s disease: a prospective cohort study , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[146]  J. Gorell,et al.  Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease , 2006, Environmental health perspectives.

[147]  D. Maraganore,et al.  Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study , 2006, Neurology.

[148]  M. Thun,et al.  Pesticide exposure and risk for Parkinson's disease , 2006, Annals of neurology.

[149]  A Hofman,et al.  Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease , 2006, Neurology.

[150]  José Luis Molinuevo,et al.  Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study , 2006, The Lancet Neurology.

[151]  C. Counsell,et al.  Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: Methods and preliminary results , 2006, Movement disorders : official journal of the Movement Disorder Society.

[152]  David Oakes,et al.  Head injury and Parkinson's disease risk in twins , 2006, Annals of neurology.

[153]  M. Hernán,et al.  Survival of Parkinson's disease patients in a large prospective cohort of male health professionals , 2006, Movement disorders : official journal of the Movement Disorder Society.

[154]  W. Kukull,et al.  Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[155]  Colin A. Johnson,et al.  PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron , 2006, Nature Genetics.

[156]  A. Wing,et al.  Blood donations, iron stores, and risk of Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[157]  P. Caramelli,et al.  Parkinsonism and Parkinson's disease in the elderly: A community‐based survey in Brazil (the Bambuí study) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[158]  D. D. De Silva,et al.  PINK1 mutations in sporadic early‐onset Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[159]  S. Rosso,et al.  Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature , 2006, Melanoma research.

[160]  F. Dick,et al.  Parkinson's disease and pesticide exposures. , 2006, British medical bulletin.

[161]  T. Gillis,et al.  Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. , 2006, Archives of neurology.

[162]  M. Musicco,et al.  Reduced Risk Factors for Vascular Disorders in Parkinson Disease Patients: A Case-Control Study , 2006, Stroke.

[163]  Julien Doyon,et al.  Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases , 2006, The Lancet Neurology.

[164]  C. Yoo,et al.  A retrospective cohort study of Parkinson's disease in Korean shipbuilders. , 2006, Neurotoxicology.

[165]  M. Hernán,et al.  Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease , 2006, Neurology.

[166]  L Zhang,et al.  Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case–control study , 2006, Acta neurologica Scandinavica.

[167]  H. Checkoway,et al.  Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. , 2006, Parkinsonism & related disorders.

[168]  K. Marder,et al.  Case-control study of the parkin gene in early-onset Parkinson disease. , 2006, Archives of neurology.

[169]  P. Silburn,et al.  Prevalence of Parkinson’s disease in metropolitan and rural Queensland: A general practice survey , 2006, Journal of Clinical Neuroscience.

[170]  R. Walker,et al.  The Prevalence of Parkinson’s Disease in an Area of North Tyneside in the North-East of England , 2006, Neuroepidemiology.

[171]  A. Singleton,et al.  Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease , 2006 .

[172]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[173]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[174]  J. Mclaughlin,et al.  Parkinson’s disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders , 2006, Occupational and Environmental Medicine.

[175]  A. Ascherio,et al.  Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease , 2006, The Journal of Neuroscience.

[176]  B. Alexander,et al.  Exposure Misclassification in Studies of Agricultural Pesticides: Insights From Biomonitoring , 2006, Epidemiology.

[177]  Nobutaka Hattori,et al.  The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. , 2005, Parkinsonism & related disorders.

[178]  Eric Jacobs,et al.  Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease , 2005, Annals of neurology.

[179]  Kevin R. Sanft,et al.  Education and occupations preceding Parkinson disease , 2005, Neurology.

[180]  A. Durr,et al.  The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson’s disease in European populations , 2005, Journal of Medical Genetics.

[181]  C. Tanner,et al.  Occupation and parkinsonism in three movement disorders clinics , 2005, Neurology.

[182]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[183]  A. Hofman,et al.  Serum uric acid levels and the risk of Parkinson disease , 2005, Annals of neurology.

[184]  Abby A. Li,et al.  Evaluation of Epidemiologic and Animal Data Associating Pesticides With Parkinson’s Disease , 2005, Journal of occupational and environmental medicine.

[185]  M. Thun,et al.  Smokeless tobacco use and the risk of Parkinson's disease mortality , 2005, Movement disorders : official journal of the Movement Disorder Society.

[186]  M. Farrer,et al.  LRRK2 mutations in Parkinson disease , 2005, Neurology.

[187]  L. Rushton,et al.  Pesticides and Parkinson’s Disease—Is There a Link? , 2005, Environmental health perspectives.

[188]  R. Hilker,et al.  Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers , 2005, Annals of neurology.

[189]  W. Oertel,et al.  Alpha‐synuclein and Parkinson's disease: Implications from the screening of more than 1,900 patients , 2005, Movement disorders : official journal of the Movement Disorder Society.

[190]  M. Farrer,et al.  The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients , 2005, Neuroscience Letters.

[191]  Albert Hofman,et al.  Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. , 2005, Archives of neurology.

[192]  J. Schulz,et al.  Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. , 2005, Human molecular genetics.

[193]  J. Gallacher,et al.  Cross‐sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom , 2005, Movement disorders : official journal of the Movement Disorder Society.

[194]  A J Lees,et al.  Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[195]  R. Marconi,et al.  Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes , 2005, Neurology.

[196]  T. Dawson,et al.  To die or grow: Parkinson's disease and cancer , 2005, Trends in Neurosciences.

[197]  B. Liu,et al.  MPP+‐induced COX‐2 activation and subsequent dopaminergic neurodegeneration , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[198]  S. Sacco,et al.  Prevalence of Parkinson's disease in the L'Aquila district, central Italy , 2005, Acta neurologica Scandinavica.

[199]  J. Jankovic.  Searching for a relationship between manganese and welding and Parkinson’s disease , 2005, Neurology.

[200]  P. J. Koudstaal,et al.  Dietary fatty acids and the risk of Parkinson disease , 2005, Neurology.

[201]  N. Hattori,et al.  Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism , 2005, Neurology.

[202]  Ali Samii,et al.  Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis , 2005, The Lancet Neurology.

[203]  D. Maraganore,et al.  Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study , 2005, Movement disorders : official journal of the Movement Disorder Society.

[204]  C. Tanner,et al.  Smell identification ability in twin pairs discordant for Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[205]  G. Logroscino,et al.  The Role of Early Life Environmental Risk Factors in Parkinson Disease: What Is the Evidence? , 2005, Environmental health perspectives.

[206]  J. Olsen,et al.  A Cohort Study of Parkinson’s Disease and Other Neurodegenerative Disorders in Danish Welders , 2005, Journal of occupational and environmental medicine.

[207]  P. Santens,et al.  Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease , 2005, Journal of the Neurological Sciences.

[208]  M. Pericak-Vance,et al.  Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease , 2005, Human Genetics.

[209]  C. Tanner,et al.  Consumption of milk and calcium in midlife and the future risk of Parkinson disease , 2005, Neurology.

[210]  E. Bastia,et al.  Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. , 2005, Pharmacology & therapeutics.

[211]  H. Chen,et al.  Physical activity and the risk of Parkinson disease , 2005, Neurology.

[212]  Zhenxin Zhang,et al.  Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai , 2005, The Lancet.

[213]  W. Scott,et al.  Family-based case-control study of cigarette smoking and Parkinson disease , 2005, Neurology.

[214]  C. Tzourio,et al.  Cigarette smoking and Parkinson's disease: A case–control study in a population characterized by a high prevalence of pesticide exposure , 2005, Movement disorders : official journal of the Movement Disorder Society.

[215]  M. Farrer,et al.  PARK11 is not linked with Parkinson's disease in European families , 2005, European Journal of Human Genetics.

[216]  Y. Pawitan,et al.  Risk and protective factors for Parkinson's disease: A study in Swedish twins , 2005, Annals of neurology.

[217]  J. Wright,et al.  Environmental Determinants of Parkinson's Disease , 2005, Archives of environmental & occupational health.

[218]  W. T. Hung,et al.  Prevalence of Parkinson's disease in Sydney , 2005, Acta neurologica Scandinavica.

[219]  J. Olsen,et al.  Atypical cancer pattern in patients with Parkinson's disease , 2004, British Journal of Cancer.

[220]  U. Bonuccelli,et al.  Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy. , 2004, Parkinsonism & related disorders.

[221]  Miguel Ángel Martínez,et al.  Genome-wide scan linkage analysis for Parkinson’s disease: the European genetic study of Parkinson’s disease , 2004, Journal of Medical Genetics.

[222]  Janel O. Johnson,et al.  Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. , 2004, Archives of neurology.

[223]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[224]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[225]  M. Thun,et al.  Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. , 2004, American journal of epidemiology.

[226]  J. Aharon-Peretz,et al.  Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2004, The New England journal of medicine.

[227]  N. Wood,et al.  PINK1 (PARK6) associated Parkinson disease in Ireland , 2004, Neurology.

[228]  A. Hofman,et al.  Incidence of parkinsonism and Parkinson disease in a general population , 2004, Neurology.

[229]  K. Marder,et al.  Smoking and Parkinson's disease. , 2004, Movement disorders : official journal of the Movement Disorder Society.

[230]  J. Fleming,et al.  Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[231]  D. Schaid,et al.  Familial aggregation of Parkinson's disease: The Mayo Clinic family study , 2004, Annals of neurology.

[232]  R. Krüger,et al.  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7) , 2004, Human mutation.

[233]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[234]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[235]  A. Bentivoglio,et al.  PINK1 mutations are associated with sporadic early‐onset parkinsonism , 2004, Annals of neurology.

[236]  M. Quik.  Smoking, nicotine and Parkinson's disease , 2004, Trends in Neurosciences.

[237]  S. Lie,et al.  Cigarette smoking in Parkinson's disease: Influence on disease progression , 2004, Movement disorders : official journal of the Movement Disorder Society.

[238]  P. Bjerregaard,et al.  Parkinson’s disease among Inuit in Greenland: organochlorines as risk factors , 2004, International journal of circumpolar health.

[239]  K. Kessler,et al.  Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.

[240]  H. Pakkenberg,et al.  High age-adjusted prevalence of Parkinson’s disease among Inuit in Greenland , 2004, International journal of circumpolar health.

[241]  Yi Zhao,et al.  Genetic analysis of DJ-1 in a cohort Parkinson’s disease patients of different ethnicity , 2004, Neuroscience Letters.

[242]  Miguel A Hernán,et al.  Folate intake and risk of Parkinson's disease. , 2004, American journal of epidemiology.

[243]  P. Grzesiowski,et al.  The antibodies against Bordetella pertussis in sera of patients with Parkinson's disease and other non‐neurological diseases , 2004, Acta neurologica Scandinavica.

[244]  H. Berendse,et al.  Idiopathic hyposmia as a preclinical sign of Parkinson's disease , 2004, Annals of neurology.

[245]  R. Mindham,et al.  Mortality in Parkinson's disease and its association with dementia and depression , 2004, Acta neurologica Scandinavica.

[246]  N. Pedersen,et al.  No evidence for heritability of Parkinson disease in Swedish twins , 2004, Neurology.

[247]  P. Ragonese,et al.  Tumor diagnosis preceding Parkinson's disease: A case–control study , 2004, Movement disorders : official journal of the Movement Disorder Society.

[248]  C. Yoo,et al.  Occupations and Parkinson's disease: a case-control study in South Korea. , 2004, Industrial health.

[249]  R. Nussbaum,et al.  Prevalence of Parkinson's disease in populations of African ancestry: a review. , 2004, Journal of the National Medical Association.

[250]  K. Marder,et al.  Lack of familial aggregation of Parkinson disease and Alzheimer disease. , 2004, Archives of neurology.

[251]  A. Singleton,et al.  Analysis of an early‐onset Parkinson's disease cohort for DJ‐1 mutations , 2004, Movement disorders : official journal of the Movement Disorder Society.

[252]  R. Doll,et al.  Mortality in relation to smoking: 50 years' observations on male British doctors , 2004, BMJ : British Medical Journal.

[253]  P. Aridon,et al.  Risk of Parkinson disease in women , 2004, Neurology.

[254]  N. Venketasubramanian,et al.  Prevalence of Parkinson disease in Singapore , 2004, Neurology.

[255]  A. Hofman,et al.  Smoking and Parkinson's disease: Systematic review of prospective studies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[256]  Yifu Deng,et al.  Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease , 2004, Annals of neurology.

[257]  G. Wooten,et al.  Postmenopausal estrogen use affects risk for Parkinson disease. , 2004, Archives of neurology.

[258]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[259]  T. Foroud,et al.  Genes influencing Parkinson disease onset , 2004, Neurology.

[260]  P. Mcgeer,et al.  Inflammation and neurodegeneration in Parkinson's disease. , 2004, Parkinsonism & related disorders.

[261]  S. Lie,et al.  Mortality and Parkinson disease , 2004, Neurology.

[262]  G. Wooten,et al.  Are men at greater risk for Parkinson’s disease than women? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[263]  Miguel A Hernán,et al.  Obesity and the risk of Parkinson's disease. , 2004, American journal of epidemiology.

[264]  J. Benito-León,et al.  Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain , 2004, Neurology.

[265]  A. Plaitakis,et al.  Bilineal transmission of Parkinson disease on Crete suggests a complex inheritance , 2004, Neurology.

[266]  T. Robbins,et al.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. , 2004, Brain : a journal of neurology.

[267]  Christophe Tzourio,et al.  CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease , 2004, Annals of neurology.

[268]  P. Lockhart,et al.  DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function , 2004, Journal of Medical Genetics.

[269]  J. Woo,et al.  Prevalence of Parkinson's disease in a Chinese population , 2004, Acta neurologica Scandinavica.

[270]  A. Bergareche,et al.  Prevalence of Parkinson’s disease and other types of Parkinsonism , 2004, Journal of Neurology.

[271]  O. Rimoldi,et al.  Cardiovascular effects of methamphetamine in Parkinson's disease patients , 2004, Movement disorders : official journal of the Movement Disorder Society.

[272]  J. Gorell,et al.  Multiple risk factors for Parkinson's disease , 2004, Journal of the Neurological Sciences.

[273]  J. Noth,et al.  DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease , 2004, Neurology.

[274]  T. Niki,et al.  DJ‐1 has a role in antioxidative stress to prevent cell death , 2004, EMBO reports.

[275]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[276]  A. Beuter,et al.  Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[277]  N. Maidment,et al.  Genetics of parkin-linked disease , 2004, Human Genetics.

[278]  D. Pineda,et al.  PREVALENCE OF PARKINSON'S DISEASE AND PARKINSONISM IN A COLOMBIAN POPULATION USING THE CAPTURE-RECAPTURE METHOD , 2004, The International journal of neuroscience.

[279]  Yi Zhao,et al.  Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese , 2003, Journal of the Neurological Sciences.

[280]  J. Growdon,et al.  A haplotype at the PARK3 locus influences onset age for Parkinson’s disease , 2003, Neurology.

[281]  J. Olsson,et al.  Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9‐year follow‐up , 2003, Movement disorders : official journal of the Movement Disorder Society.

[282]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[283]  J. Jankovic,et al.  Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families. , 2003, Human molecular genetics.

[284]  K. Marder,et al.  Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD , 2003, Neurology.

[285]  J. Allum,et al.  The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism , 2003, Neurology.

[286]  A Ghetti,et al.  Lifestyle‐related risk factors for Parkinson's disease: a population‐based study , 2003, Acta neurologica Scandinavica.

[287]  A. Nicoletti,et al.  Prevalence of Parkinson's disease: a door-to-door survey in rural Bolivia. , 2003, Parkinsonism & related disorders.

[288]  Karen Marder,et al.  Familial aggregation of early‐ and late‐onset Parkinson's disease , 2003, Annals of neurology.

[289]  S. Lewis,et al.  Occupational exposure to solvents and metals and Parkinson’s disease , 2003, Neurology.

[290]  Donato A Di Monte,et al.  The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? , 2003, The Lancet Neurology.

[291]  J. Hubble,et al.  Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD , 2003, Neurology.

[292]  P. Aridon,et al.  A Case-Control Study on Cigarette, Alcohol, and Coffee Consumption Preceding Parkinson’s Disease , 2003, Neuroepidemiology.

[293]  J. Dartigues,et al.  Association between Parkinson’s Disease and Exposure to Pesticides in Southwestern France , 2003, Neuroepidemiology.

[294]  A. Leentjens,et al.  The Incidence of Parkinson’s Disease in the Netherlands: Results from a Longitudinal General Practice-Based Registration , 2003, Neuroepidemiology.

[295]  M. Hernán,et al.  Alcohol consumption and the incidence of Parkinson's disease , 2003, Annals of neurology.

[296]  C. V. van Duijn,et al.  Parkinson's disease: piecing together a genetic jigsaw. , 2003, Brain : a journal of neurology.

[297]  W. Willett,et al.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. , 2003, Archives of neurology.

[298]  D. Schaid,et al.  Validity of family history data on PD , 2003, Neurology.

[299]  P. Heutink,et al.  Familial influence on parkinsonism in a rural area of Turkey (Kızılcaboluk–Denizli): A community‐based case‐control study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[300]  W. Longstreth,et al.  Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes , 2003, Neurology.

[301]  Miguel A Hernán,et al.  Dietary intakes of fat and risk of Parkinson's disease. , 2003, American journal of epidemiology.

[302]  Zhenxin Zhang,et al.  Parkinson's disease and smoking: an integral part of PD's etiological study. , 2003, Biomedical and environmental sciences : BES.

[303]  B. Liu,et al.  Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. , 2003, Environmental health perspectives.

[304]  Lorene M Nelson,et al.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. , 2003, American journal of epidemiology.

[305]  D. Maraganore,et al.  Head trauma preceding PD , 2003, Neurology.

[306]  L. Seeberger,et al.  Significant linkage of Parkinson disease to chromosome 2q36-37. , 2003, American journal of human genetics.

[307]  Nir Giladi,et al.  Higher incidence of depression preceding the onset of Parkinson's disease: A register study , 2003, Movement disorders : official journal of the Movement Disorder Society.

[308]  F. Speizer,et al.  Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease , 2003, Neurology.

[309]  L. Seeberger,et al.  Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease , 2003, Neurology.

[310]  Julián Benito-León,et al.  Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain , 2003, Movement disorders : official journal of the Movement Disorder Society.

[311]  J. Dartigues,et al.  Neurodegenerative diseases and exposure to pesticides in the elderly. , 2003, American journal of epidemiology.

[312]  D. Aarsland,et al.  Familial Parkinson's disease: a community‐based study , 2003, European journal of neurology.

[313]  K. Teschke,et al.  The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology. , 2003, Parkinsonism & related disorders.

[314]  P. Taba,et al.  Incidence of Parkinson’s Disease in Estonia , 2003, Neuroepidemiology.

[315]  D. Twelves,et al.  Systematic review of incidence studies of Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[316]  M. Allam,et al.  Parkinson's disease, smoking and family history: meta‐analysis , 2003, European journal of neurology.

[317]  K. Marder,et al.  The association of incident dementia with mortality in PD , 2002, Neurology.

[318]  Miguel A Hernán,et al.  Diet and Parkinson's disease: A potential role of dairy products in men , 2002, Annals of neurology.

[319]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[320]  T. Hashimoto,et al.  Incidence of Parkinson Disease in Wakayama, Japan , 2002, Journal of epidemiology.

[321]  L. Cameron,et al.  Proportionate mortality of crop and livestock farmers in the United States, 1984-1993. , 2002, American journal of industrial medicine.

[322]  C. Tanner,et al.  Plantation work and risk of Parkinson disease in a population-based longitudinal study. , 2002, Archives of neurology.

[323]  P. Taba,et al.  Prevalence of Parkinson's disease in Estonia , 2002, Acta neurologica Scandinavica.

[324]  D Spiegelman,et al.  Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk , 2002, Neurology.

[325]  C. Tanner,et al.  Midlife adiposity and the future risk of Parkinson’s disease , 2002, Neurology.

[326]  A. Manning-Boğ,et al.  Environmental factors in Parkinson's disease. , 2002, Neurotoxicology.

[327]  Miguel A Hernán,et al.  A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease , 2002, Annals of neurology.

[328]  F. Chang,et al.  Environmental risk factors of young onset Parkinson's disease: a case-control study , 2002, Clinical Neurology and Neurosurgery.

[329]  T. Foroud,et al.  Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. , 2002, American journal of human genetics.

[330]  J. Langston,et al.  Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat , 2002, Neurobiology of Disease.

[331]  A. Schrag,et al.  Novel three-stage ascertainment method , 2002, Neurology.

[332]  T. Sherer,et al.  Environment, Mitochondria, and Parkinson's Disease , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[333]  Bin Liu,et al.  Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease , 2002, Journal of neurochemistry.

[334]  L. Shulman.  Is there a connection between estrogen and Parkinson's disease? , 2002, Parkinsonism & related disorders.

[335]  K Teschke,et al.  Occupational and environmental risk factors for Parkinson's disease. , 2002, Parkinsonism & related disorders.

[336]  J A Knottnerus,et al.  Increased risk of Parkinson’s disease after depression: A retrospective cohort study , 2002, Neurology.

[337]  M. Hernán,et al.  MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD , 2002, Neurology.

[338]  H. Pakkenberg,et al.  High age-adjusted prevalence of Parkinson’s disease among Inuits in Greenland , 2002, Neurology.

[339]  M. MacDonald,et al.  PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. , 2002, American journal of human genetics.

[340]  J. Nutt,et al.  Familial aggregation of Parkinson disease: a comparative study of early-onset and late-onset disease. , 2002, Archives of neurology.

[341]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[342]  Harvey Checkoway,et al.  Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. , 2002, American journal of epidemiology.

[343]  Rajesh Pahwa,et al.  Age at onset in two common neurodegenerative diseases is genetically controlled. , 2002, American journal of human genetics.

[344]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[345]  N. Rothman,et al.  A quantitative approach for estimating exposure to pesticides in the Agricultural Health Study. , 2002, The Annals of occupational hygiene.

[346]  S. Tsuji,et al.  A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1 , 2002, Annals of neurology.

[347]  J. Duarte,et al.  Prevalence of Parkinson's disease in Cantalejo, Spain: A door‐to‐door survey , 2002, Movement disorders : official journal of the Movement Disorder Society.

[348]  D. Maraganore,et al.  Nonfatal Cancer Preceding Parkinson’s Disease: A Case-Control Study , 2002, Epidemiology.

[349]  R. Mayeux,et al.  Smoking and Parkinson’s disease in twins , 2002, Neurology.

[350]  R. Zivadinov,et al.  Familial and environmental risk factors in Parkinson's disease: a case–control study in north‐east Italy , 2002, Acta neurologica Scandinavica.

[351]  J. Reif,et al.  Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases. , 2002, Scandinavian journal of work, environment & health.

[352]  J. Growdon,et al.  Epidemiologic study of 203 sibling pairs with Parkinson’s disease , 2002, Neurology.

[353]  C. Naylor,et al.  Parkinsonism in Ontario , 2001, Neurology.

[354]  Nir Giladi,et al.  Cross-Sectional Study of the Prevalence of Parkinson’s Disease in the Kibbutz Movement in Israel , 2001, Neuroepidemiology.

[355]  F. Speizer,et al.  Cigarette smoking and the incidence of Parkinson's disease in two prospective studies , 2001, Annals of neurology.

[356]  J. Haines,et al.  Complete genomic screen in Parkinson disease: evidence for multiple genes. , 2001, JAMA.

[357]  T. Chen,et al.  Prevalence, incidence, and mortality of PD , 2001, Neurology.

[358]  L. Kessing,et al.  Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. , 2001 .

[359]  Andrew J. Lees,et al.  Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease , 2001, Neurology.

[360]  H. Helenius,et al.  Familial occurrence of Parkinson's disease in a community-based case-control study. , 2001, Parkinsonism & related disorders.

[361]  P. Jansen,et al.  Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records , 2001, Pharmacoepidemiology and drug safety.

[362]  W. Rocca,et al.  Problems and Issues with Door-To-Door, Two-Phase Surveys: An Illustration from Central Spain , 2001, Neuroepidemiology.

[363]  P. Vieregge,et al.  Transdermal nicotine in PD , 2001, Neurology.

[364]  M Behari,et al.  Risk factors of Parkinson's disease in Indian patients , 2001, Journal of the Neurological Sciences.

[365]  D. Hernandez,et al.  Lewy bodies and parkinsonism in families with parkin mutations , 2001, Annals of neurology.

[366]  A. Singleton,et al.  Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes , 2001, European Journal of Human Genetics.

[367]  D. Schaid,et al.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[368]  R. Camicioli,et al.  Parkinsonism and occupational exposure to pesticides , 2001, Occupational and environmental medicine.

[369]  V. Uversky,et al.  Pesticides directly accelerate the rate of α‐synuclein fibril formation: a possible factor in Parkinson's disease , 2001, FEBS letters.

[370]  W. Willett,et al.  Prospective study of caffeine consumption and risk of Parkinson's disease in men and women , 2001, Annals of neurology.

[371]  H. Berendse,et al.  Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell , 2001, Annals of neurology.

[372]  Nobutaka Hattori,et al.  Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.

[373]  C. C. Johnson,et al.  Occupational categories at risk for Parkinson's disease. , 2001, American journal of industrial medicine.

[374]  A. Paganini-Hill.  Risk Factors for Parkinson’s Disease: The Leisure World Cohort Study , 2001, Neuroepidemiology.

[375]  J. Goldsmith,et al.  A Case-Control Study of Parkinson's Disease in Urban Population of Southern Israel , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[376]  A. Bentivoglio,et al.  Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. , 2001, American journal of human genetics.

[377]  M. Tatemichi,et al.  Meta-analysis for epidemiologic studies on the relationship between smoking and Parkinson's disease. , 2001, Journal of epidemiology.

[378]  Glenda M. Halliday,et al.  Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation , 2001 .

[379]  A. Mitsumoto,et al.  DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin , 2001, Free radical research.

[380]  E. Richfield,et al.  The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease , 2000, The Journal of Neuroscience.

[381]  A A Hicks,et al.  Familial aggregation of Parkinson's disease in Iceland. , 2000, The New England journal of medicine.

[382]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[383]  B. Jeune,et al.  A two‐fold difference in the age‐adjusted prevalences of Parkinson’s disease between the island of Als and the Faroe Islands , 2000, European journal of neurology.

[384]  J. Dartigues,et al.  Parkinson's disease, smoking and family history , 2000, Journal of Neurology.

[385]  D. Schaid,et al.  Smoking, alcohol, and coffee consumption preceding Parkinson’s disease , 2000, Neurology.

[386]  D. Inzitari,et al.  Parkinson’s disease and parkinsonism in a longitudinal study , 2000, Neurology.

[387]  R. Fuente-Fernández.  Maternal effect on Parkinson's disease. , 2000 .

[388]  M. Druet‐Cabanac,et al.  Parkinson’s Disease and Environmental Factors , 2000, Neuroepidemiology.

[389]  C. Johansen.  Exposure to Electromagnetic Fields and Risk of Central Nervous System Disease in Utility Workers , 2000, Epidemiology.

[390]  D. Maraganore,et al.  Influence of strict, intermediate, and broad diagnostic criteria on the age‐ and sex‐specific incidence of Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[391]  A. A. Jensen,et al.  Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993. , 2000, Scandinavian journal of work, environment & health.

[392]  Hui-Xin Wang,et al.  Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studies , 2000, Behavioural Brain Research.

[393]  S. Khuder,et al.  A meta-analysis of Parkinson's disease and exposure to pesticides. , 2000, Neurotoxicology.

[394]  D. Schaid,et al.  Anxiety disorders and depressive disorders preceding Parkinson's disease: A case‐control study , 2000, Movement disorders : official journal of the Movement Disorder Society.

[395]  K. Majamaa,et al.  Familial aggregation of Parkinson's disease in a Finnish population , 2000, Journal of neurology, neurosurgery, and psychiatry.

[396]  Y Ben-Shlomo,et al.  Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London , 2000, BMJ : British Medical Journal.

[397]  Y. Minami,et al.  Mortality and cancer incidence in patients with Parkinson's disease , 2000, Journal of Neurology.

[398]  C. Tanner,et al.  Association of coffee and caffeine intake with the risk of Parkinson disease. , 2000, JAMA.

[399]  P. Morrish,et al.  Parkinson's disease in twins. , 2000, Neurology.

[400]  P. Ragonese,et al.  Parkinson disease survival: a population-based study. , 2000, Archives of neurology.

[401]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[402]  J. Rinne,et al.  Risk for Parkinson’s disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET , 2000, Journal of Neurology.

[403]  B. Ritz,et al.  Parkinson's disease mortality and pesticide exposure in California 1984-1994. , 2000, International journal of epidemiology.

[404]  C. L. Wienburg,et al.  Organochlorine insecticides in substantia nigra in Parkinson's disease. , 2000, Journal of toxicology and environmental health. Part A.

[405]  R. Marconi,et al.  Smoking habits in multiple system atrophy and progressive supranuclear palsy , 2000, Neurology.

[406]  L. Cupples,et al.  Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. , 1999, American journal of medical genetics.

[407]  C. C. Johnson,et al.  Adult nutrient intake as a risk factor for Parkinson's disease. , 1999, International journal of epidemiology.

[408]  H. Helenius,et al.  Environmental risk factors in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[409]  D. Calne,et al.  Occupational risk factors in Parkinson's disease. , 1999, Canadian journal of public health = Revue canadienne de sante publique.

[410]  M. Hely,et al.  The Sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years , 1999, Journal of neurology, neurosurgery, and psychiatry.

[411]  J. Gorell,et al.  A Family History of Parkinson’s Disease and Its Effect on Other PD Risk Factors , 1999, Neuroepidemiology.

[412]  P. Vieregge,et al.  Parkinson’s disease in twins , 1999, Neurology.

[413]  K. Mönkemüller,et al.  Paraneoplastic disorders associated with seminoma. , 1999, Neurology.

[414]  J. De Pedro-Cuesta,et al.  Prevalence of Parkinson's disease in lower Aragon, Spain , 1999, Movement disorders : official journal of the Movement Disorder Society.

[415]  R. Dobbs,et al.  Association of circulating TNF‐α and IL‐6 with ageing and parkinsonism , 1999 .

[416]  A. L. Werneck,et al.  Genetics, drugs and environmental factors in Parkinson's disease. A case-control study. , 1999, Arquivos de neuro-psiquiatria.

[417]  C. Tzourio,et al.  Familial aggregation of Parkinson’s disease , 1999, Neurology.

[418]  Paola Piccini,et al.  The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins , 1999, Annals of neurology.

[419]  S. Fahn,et al.  The effect of estrogen replacement on early Parkinson’s disease , 1999, Neurology.

[420]  A. Mankodi,et al.  Acute and reversible parkinsonism due to organophosphate pesticide intoxication , 1999, Neurology.

[421]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[422]  C. C. Johnson,et al.  Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. , 1999, Neurotoxicology.

[423]  A J McLean,et al.  Pesticides and Parkinson's disease. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[424]  K. Marder,et al.  Risk of Alzheimer’s disease in relatives of Parkinson’s disease patients with and without dementia , 1999, Neurology.

[425]  K. Müller-Vahl,et al.  Transient severe parkinsonism after acute organophosphate poisoning , 1999, Journal of neurology, neurosurgery, and psychiatry.

[426]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[427]  O. Axelson,et al.  Nutritional and occupational factors influencing the risk of Parkinson's disease: A case‐control study in southeastern Sweden , 1999, Movement disorders : official journal of the Movement Disorder Society.

[428]  H Checkoway,et al.  Dietary factors in Parkinson's disease: The role of food groups and specific foods , 1999, Movement disorders : official journal of the Movement Disorder Society.

[429]  H Helenius,et al.  Changing epidemiology of Parkinson’s disease in southwestern Finland , 1999, Neurology.

[430]  C. C. Johnson,et al.  Smoking and Parkinson’s disease , 1999, Neurology.

[431]  G. Meco,et al.  Mortality cancer risk in parkinsonian patients: A population-based study , 1999, Neurology.

[432]  W. T. Hung,et al.  Genetic and environmental risk factors for Parkinson’s disease in a Chinese population , 1998, Journal of neurology, neurosurgery, and psychiatry.

[433]  A. Blackburn,et al.  Parkinson's disease, pesticides, and glutathione transferase polymorphisms , 1998, The Lancet.

[434]  C. Brayne,et al.  The Epidemiology of Parkinson’s Disease in an Australian Population , 1998, Neuroepidemiology.

[435]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[436]  G. Mellick,et al.  Cost-effectiveness model of adjunctive lamotrigine for the treatment of epilepsy , 1998, Neurology.

[437]  A. Smargiassi,et al.  A case-control study of occupational and environmental risk factors for Parkinson's disease in the Emilia-Romagna region of Italy. , 1998, Neurotoxicology.

[438]  D. Savitz,et al.  Magnetic Field Exposure and Neurodegenerative Disease Mortality among Electric Utility Workers , 1998, Epidemiology.

[439]  D. Maraganore,et al.  Case ascertainment uncertainties in prevalence surveys of Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[440]  K. Jellinger,et al.  Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. , 1998, Archives of neurology.

[441]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[442]  D. Woitalla,et al.  High prevalence of parkinsonism after occupational exposure to lead‐sulfate batteries , 1998, Neurology.

[443]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[444]  C. C. Johnson,et al.  The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living , 1998, Neurology.

[445]  H. Checkoway,et al.  A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease , 1998, Neurology.

[446]  A. Chiò,et al.  Prevalence of Parkinson's disease in northwestern italy: Comparison of tracer methodology and clinical ascertainment of cases , 1998, Movement disorders : official journal of the Movement Disorder Society.

[447]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[448]  K. Marder,et al.  Systemic iron metabolism and mortality from Parkinson's disease , 1998, Neurology.

[449]  K. Marder,et al.  Postmenopausal estrogen use and Parkinson's disease with and without dementia , 1998, Neurology.

[450]  B. Müller-Myhsok,et al.  A susceptibility locus for Parkinson's disease maps to chromosome 2p13 , 1998, Nature Genetics.

[451]  J S Rakshi,et al.  Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET , 1998, Journal of neurology, neurosurgery, and psychiatry.

[452]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[453]  K. Marder,et al.  Environmental risk factors for Parkinson's disease in an urban multiethnic community , 1998, Neurology.

[454]  G. Meco,et al.  Mortality in a population‐based cohort of patients treated with antiparkinsonian drugs , 1998, Acta neurologica Scandinavica.

[455]  C. Tzourio,et al.  Smoking and Parkinson's disease , 1997, Neurology.

[456]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[457]  B. Jeune,et al.  High prevalence of Parkinson's disease in the Faroe Islands , 1997, Neurology.

[458]  Richard Mayeux,et al.  Diet and Parkinson's disease , 1997, Neurology.

[459]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[460]  J. Jeng,et al.  Environmental risk factors and Parkinson's disease , 1997, Neurology.

[461]  A. Hofman,et al.  Dietary antioxidants and Parkinson disease. The Rotterdam Study. , 1997, Archives of neurology.

[462]  D. Maraganore,et al.  A population perspective on diagnostic criteria for Parkinson's disease , 1997, Neurology.

[463]  S. Daniel,et al.  Olfactory dysfunction in Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[464]  B. Hiner,et al.  Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease , 1997, Neurology.

[465]  A. Seidler,et al.  Smoking and Parkinson's disease: a case-control study in Germany. , 1997, International journal of epidemiology.

[466]  Y Ben-Shlomo,et al.  The epidemiology of Parkinson's disease. , 1997, Bailliere's clinical neurology.

[467]  Gregory G. Brown,et al.  Occupational exposures to metals as risk factors for Parkinson's disease , 1997, Neurology.

[468]  W. Rocca,et al.  Prevalence of Parkinson's disease in junín, Buenos Aires province, argentina , 1997, Movement disorders : official journal of the Movement Disorder Society.

[469]  E D Louis,et al.  Mortality from Parkinson disease. , 1997, Archives of neurology.

[470]  J. Freudenheim,et al.  Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[471]  J. Dartigues,et al.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[472]  R. Pfeiffer,et al.  Descriptive Epidemiology of Parkinson’s Disease through Proxy Measures , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[473]  A. Seidler,et al.  Diet and Parkinson's disease I , 1996, Neurology.

[474]  D. Morens,et al.  Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. , 1996, American journal of epidemiology.

[475]  G. Ulm,et al.  Diet and Parkinson's disease II , 1996, Neurology.

[476]  K. Marder,et al.  Risk of Parkinson's disease among first-degree relatives , 1996, Neurology.

[477]  A. Ishikawa,et al.  Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism , 1996, Neurology.

[478]  O. Axelson,et al.  Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. , 1996, Journal of clinical epidemiology.

[479]  D. Weatherall,et al.  Oxford textbook of medicine , 1996 .

[480]  D. Morens,et al.  Case‐control study of idiopathic Parkinson's disease and dietary vitamin E intake , 1996, Neurology.

[481]  A. Seidler,et al.  Possible environmental, occupational, and other etiologic factors for Parkinson's disease , 1996, Neurology.

[482]  E. van der Velde,et al.  Clinical course of patients with idiopathic Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.

[483]  D. Morens,et al.  Epidemiologic observations on Parkinson's disease , 1996, Neurology.

[484]  S. Kikuchi,et al.  Prevalence of Parkinson's disease in Hokkaido, the northernmost island of Japan. , 1996, Internal medicine.

[485]  W. Rocca,et al.  Occupation, education, and Parkinson's disease: A case‐control study in an Italian population , 1996, Movement disorders : official journal of the Movement Disorder Society.

[486]  M. Pawlikowski,et al.  Evaluation of interleukins, ACTH, cortisol and prolactin concentrations in the blood of patients with parkinson's disease. , 1996, Neuroimmunomodulation.

[487]  Josemir W Sander,et al.  Neurological disease in a defined population: the results of a pilot study in two general practices. , 1996, Neuroepidemiology.

[488]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[489]  Karen Marder,et al.  Dietary lipids and antioxidants in Parkinson's disease: A population‐based, case‐control study , 1996, Annals of neurology.

[490]  R. Marconi,et al.  Environmental and genetic risk factors in Parkinson's disease: A case–control study in southern italy , 1996, Movement disorders : official journal of the Movement Disorder Society.

[491]  J. Meara,et al.  Parkinson's disease epidemiology in the Northampton District, England, 1992 , 1995, Acta neurologica Scandinavica.

[492]  A Hofman,et al.  Prevalence of Parkinson's disease in the elderly , 1995, Neurology.

[493]  G. Meco,et al.  Familial Parkinson’s Disease: A Clinical Genetic Analysis , 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[494]  K. Marder,et al.  The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. , 1995, American journal of epidemiology.

[495]  C Trenkwalder,et al.  Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. , 1995, Archives of neurology.

[496]  J. Hubble,et al.  Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study , 1995, Journal of clinical microbiology.

[497]  C. Osmond,et al.  Parkinson's disease and the environment in early life , 1995, Journal of the Neurological Sciences.

[498]  G. Paulson,et al.  Are death certificates reliable to estimate the incidence of Parkinson's disease? , 1995, Movement disorders : official journal of the Movement Disorder Society.

[499]  T. Riise,et al.  The epidemiology of Parkinson's disease in the county of Rogaland, Norway , 1995, Movement disorders : official journal of the Movement Disorder Society.

[500]  R. Petersen,et al.  No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[501]  V. Hachinski,et al.  Environmental Exposures in Elderly Canadians With Parkinson’s Disease , 1995, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[502]  J. Boldsen,et al.  Mortality in patients with Parkinson's disease , 1995, Acta neurologica Scandinavica.

[503]  G. Meco,et al.  Estimate of parkinsonism prevalence through drug prescription histories in the Province of Rome, Italy , 1995, Acta neurologica Scandinavica.

[504]  J. Olsen,et al.  Occurrence of different cancers in patients with Parkinson's disease , 1995, BMJ.

[505]  H. Okada,et al.  The substantia nigra is a major target for neurovirulent influenza A virus , 1995, The Journal of experimental medicine.

[506]  D. Morens,et al.  Cigarette smoking and protection from Parkinson's disease , 1995, Neurology.

[507]  F. Jiménez-Jiménez,et al.  Serum and urinary manganese levels in patients with Parkinson's disease , 1995, Acta neurologica Scandinavica.

[508]  Y. Imaizumi.  Geographical variations in mortality from Parkinson's disease in Japan, 1977–1985 , 1995, Acta neurologica Scandinavica.

[509]  M. Marmot,et al.  Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? , 1995, Journal of neurology, neurosurgery, and psychiatry.

[510]  W. H. Church,et al.  Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidation , 1994, Brain Research Bulletin.

[511]  M. Felgueiras,et al.  The prevalence of Parkinson's disease in Portugal , 1994, European Journal of Epidemiology.

[512]  J. Nutt,et al.  Increased risk of Parkinson's disease in parents and siblings of patients , 1994, Annals of neurology.

[513]  C. C. Johnson,et al.  Parkinson's disease and its comorbid disorders , 1994, Neurology.

[514]  A. Alpérovitch,et al.  Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France , 1994, Acta neurologica Scandinavica.

[515]  K. Herholz,et al.  Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits , 1994, Annals of neurology.

[516]  N Vanacore,et al.  Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). , 1994, Scandinavian journal of work, environment & health.

[517]  L. Fleming,et al.  Parkinson's disease and brain levels of organochlorine pesticides , 1994, Annals of neurology.

[518]  C. Clark,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Neurology.

[519]  D. Morens,et al.  Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. , 1994, American journal of epidemiology.

[520]  E. Granieri,et al.  Prevalence of anti‐parkinson drugs’ use in Ferrara, Northern Italy, 1988 , 1994, Acta neurologica Scandinavica.

[521]  A. Mubaidin,et al.  Pallido‐pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor‐Rakeb syndrome , 1994, Acta neurologica Scandinavica.

[522]  F. Jiménez-Jiménez,et al.  Risk‐factors for Parkinson's disease: case‐control study in the province of Cáceres, Spain , 1994, Acta neurologica Scandinavica.

[523]  S. Tsuji,et al.  Familial juvenile parkinsonism , 1994, Neurology.

[524]  L. Svenson,et al.  Geographic Variations in the Prevalence Rates of Parkinson’s Disease in Alberta , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[525]  X M Cheng,et al.  A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. , 1993, Neuroepidemiology.

[526]  C. Buncher,et al.  Birthplace as a risk factor in motor neurone disease and Parkinson's disease. , 1993, International journal of epidemiology.

[527]  D. Maraganore,et al.  Levodopa therapy and survival in idiopathic Parkinson's disease , 1993, Neurology.

[528]  J. Hubble,et al.  Risk factors for Parkinson's disease , 1993, Neurology.

[529]  F. Jiménez-Jiménez,et al.  Serum levels of ascorbic acid (vitamin C) in patients with Parkinson's disease , 1993, Journal of the Neurological Sciences.

[530]  M. Catalán,et al.  Serum levels of β-carotene and other carotenoids in Parkinson's disease , 1993, Neuroscience Letters.

[531]  J. Nutt,et al.  Environmental antecedents of young‐onset Parkinson's disease , 1993, Neurology.

[532]  R. G. Lee,et al.  Parkinson's disease , 1993, Neurology.

[533]  T. Beaty,et al.  Fundamentals of Genetic Epidemiology , 1993 .

[534]  B. Winblad,et al.  Risk factors for late‐ onset Alzheimer's disease: A population‐ based, case‐control study , 1993, Annals of neurology.

[535]  M. Brin,et al.  Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.

[536]  A. Tomkins,et al.  Diet, body size and micronutrient status in Parkinson's disease. , 1992, European journal of clinical nutrition.

[537]  A. E. Harding,et al.  Parkinson's disease in twins studied with 18F‐dopa and positron emission tomography , 1992, Neurology.

[538]  W. Rocca,et al.  Prevalence of Parkinson's disease and other types of parkinsonism , 1992, Neurology.

[539]  F. Jiménez-Jiménez,et al.  Serum levels of vitamin A in Parkinson's disease , 1992, Journal of the Neurological Sciences.

[540]  J. Playfer,et al.  Concentrations of vitamins A, C and E in elderly patients with Parkinson's disease. , 1992, Postgraduate medical journal.

[541]  J. Silverman,et al.  A case‐control study of Alzheimer's disease in China , 1992, Neurology.

[542]  H P Ludin,et al.  Parkinson's disease in twins , 1992, Neurology.

[543]  E. Love,et al.  Parkinson's disease and exposure to agricultural work and pesticide chemicals , 1992, Neurology.

[544]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[545]  F. Jiménez-Jiménez,et al.  Serum levels of alpha‐tocopherol (vitamin E) in Parkinson's disease , 1992, Neurology.

[546]  P. Vieregge,et al.  Life-style and Dietary Factors Early and Late in Parkinson’s Disease , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[547]  J. Riggs,et al.  Cigarette smoking and Parkinson disease: the illusion of a neuroprotective effect. , 1992, Clinical neuropharmacology.

[548]  R. Paffenbarger,et al.  The role of physical exercise in the occurrence of Parkinson's disease. , 1992, Archives of neurology.

[549]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[550]  G. Rosati,et al.  Acute and persistent parkinsonism after use of diquat , 1992, Neurology.

[551]  Y. M. Shi,et al.  Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA. , 1991, Chinese medical journal.

[552]  P C O'Brien,et al.  Brain injury and neurologic sequelae , 1991, Neurology.

[553]  S. Gruber,et al.  The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. , 1991 .

[554]  A. Rajput,et al.  Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[555]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[556]  E. Love,et al.  Parkinson's Disease and Exposure to Rural Environmental Factors: A Population Based Case-Control Study , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[557]  M. Carreras,et al.  Parkinson's disease in Ferrara, Italy, 1967 through 1987. , 1991, Archives of neurology.

[558]  W. Koller,et al.  Environmental risk factors in siblings with Parkinson's disease. , 1991, Archives of neurology.

[559]  A. Hofman,et al.  Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. , 1991, International journal of epidemiology.

[560]  Klaus P. Ebmeier,et al.  Mortality and Causes of Death in Idiopathic Parkinson's Disease: Results from the Aberdeen Whole Population Study , 1990, Scottish medical journal.

[561]  T. Koepsell,et al.  A case‐control study of Alzheimer's disease , 1990, Annals of neurology.

[562]  R. Paffenbarger,et al.  Smoking and Parkinson's Disease , 1990, Epidemiology.

[563]  C. Tanner,et al.  Environmental risk factors in Parkinson's disease , 1990, Neurology.

[564]  E. Granieri,et al.  Epidemiology of Parkinson's disease in Italy. A descriptive survey in the U.S.L. of Cento, province of Ferrara, Emilia-Romagna. , 1990, Acta neurologica.

[565]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[566]  J. Goldsmith,et al.  Clustering of Parkinson's disease points to environmental etiology. , 1990, Archives of environmental health.

[567]  A. Hofman,et al.  History of dementia and Parkinson's disease in 1st‐degree relatives of patients with Alzheimer's disease , 1989, Neurology.

[568]  S. Ho,et al.  Epidemiologic study of Parkinson's disease in Hong Kong , 1989, Neurology.

[569]  C. Hertzman,et al.  A community survey of Parkinson's disease. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[570]  Klaus P. Ebmeier,et al.  Does idiopathic parkinsonism in Aberdeen follow intrauterine influenza? , 1989, Journal of neurology, neurosurgery, and psychiatry.

[571]  C. Tanner,et al.  Environmental factors and Parkinson's disease , 1989, Neurology.

[572]  C H Ngim,et al.  Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease. , 1989, Neuroepidemiology.

[573]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[574]  L. Golbe,et al.  Case-control study of early life dietary factors in Parkinson's disease. , 1988, Archives of neurology.

[575]  A. Bharucha,et al.  Prevalence of Parkinson's disease in the Parsi community of Bombay, India. , 1988, Archives of neurology.

[576]  J. Kurtzke,et al.  Parkinsonism death rates by race, sex, and geography , 1988, Neurology.

[577]  J. Kaprio,et al.  Parkinson's disease in a nationwide twin cohort , 1988, Neurology.

[578]  R. Doty,et al.  Olfactory dysfunction in parkinsonism , 1988, Neurology.

[579]  W. Koller,et al.  Lack of association between essential tremor and Parkinson's disease , 1988, Annals of neurology.

[580]  M. Marmot,et al.  Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[581]  A. Chakravarti,et al.  Risk of dementia in relatives of patients with Alzheimer's disease , 1988, Neurology.

[582]  B. Osuntokun,et al.  Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria , 1988, Neurology.

[583]  R. Marttila,et al.  Parkinson's disease and essential tremor in families of patients with early-onset Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[584]  C. Marsden,et al.  INCREASED NIGRAL IRON CONTENT IN POSTMORTEM PARKINSONIAN BRAIN , 1987, The Lancet.

[585]  E. Granieri,et al.  Prevalence of Parkinson's disease in the Republic of San Marino , 1987, Neurology.

[586]  C. Tanner,et al.  Environmental Factors in the Etiology of Parkinson's Disease , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[587]  M. Lerner,et al.  SKIN COLOUR, MPTP, AND PARKINSON'S DISEASE , 1987, The Lancet.

[588]  B. Henderson,et al.  A Prospective Study” , 2007 .

[589]  L. Kurland,et al.  A case‐control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease , 1987, Neurology.

[590]  B. Osuntokun,et al.  Neurological disorders in Nigerian Africans: a community‐based study , 1987, Acta neurologica Scandinavica.

[591]  C. Marsden.  Parkinson's disease in twins. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[592]  K. Radhakrishnan,et al.  Epidemiology of Parkinson's disease in Benghazi, North-East Libya , 1986, Clinical Neurology and Neurosurgery.

[593]  G. Corsini,et al.  PARKINSON'S DISEASE AND PESTICIDES , 1986, The Lancet.

[594]  L. Golbe,et al.  Smoking and Parkinson's disease. Search for a dose-response relationship. , 1986, Archives of neurology.

[595]  R. Ionasescu,et al.  Prenatal diagnosis of Duchenne muscular dystrophy based on Xp21.2 deletion , 1986, Neurology.

[596]  E. Otero,et al.  Parkinson's Disease: A Genetic Study , 1986, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[597]  L. Fratiglioni,et al.  Risk factors for clinically diagnosed Alzheimer's disease , 1986, Neurology.

[598]  S. Roy,et al.  Parkinson's disease in a Scottish city. , 1986, British medical journal.

[599]  J G Nutt,et al.  A case‐control study of twin pairs discordant for Parkinson's disease , 1986, Neurology.

[600]  R. Paffenbarger,et al.  Measles infection and Parkinson's disease. , 1985, American journal of epidemiology.

[601]  R. Sutcliffe,et al.  Parkinson's disease in the district of the Northampton Health Authority, United Kingdom. A study of prevalence and disability , 1985, Acta neurologica Scandinavica.

[602]  R. Wallace,et al.  Health status of the rural elderly according to farm work history: the Iowa 65 + rural health study. , 1985, Archives of environmental health.

[603]  B. Schoenberg,et al.  A prevalence survey of Parkinson's disease and other movement disorders in the People's Republic of China. , 1985, Archives of neurology.

[604]  Dallas W. Anderson,et al.  Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi , 1985, Neurology.

[605]  J. Jankovic,et al.  Low cancer rates among patients with Parkinson's disease , 1985, Annals of neurology.

[606]  J. Jankovic,et al.  Association between essential tremor and Parkinson's disease , 1985, Annals of neurology.

[607]  K P Offord,et al.  Epidemiology of parkinsonism: Incidence, classification, and mortality , 1984, Annals of neurology.

[608]  L. Kurland,et al.  Essential tremor in Rochester, Minnesota: a 45-year study. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[609]  C. Ward,et al.  Parkinson's disease in 65 pairs of twins and in a set of quadruplets , 1983, Neurology.

[610]  K. Takahashi,et al.  Epidemiology of Parkinson's disease in a Japanese city. , 1983, Archives of neurology.

[611]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[612]  J. Dankert,et al.  PENICILLIN-SENSITIVE STREPTOCOCCAL ENDOCARDITIS , 1982, The Lancet.

[613]  W. Foege,et al.  1918 INFLUENZA, ENCEPHALITIS LETHARGICA, PARKINSONISM , 1982, The Lancet.

[614]  R. Godwin-Austen,et al.  Smoking and Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[615]  C. Hogstedt,et al.  Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury--a case-referent study. , 1981, Scandinavian journal of work, environment & health.

[616]  B. Ames,et al.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[617]  R. Baumann,et al.  Nicotine exposure and Parkinson disease. , 1981, American journal of epidemiology.

[618]  Toshiki Ogawa.  Personality Characteristics of Parkinson's Disease , 1981, Perceptual and motor skills.

[619]  R. Duvoisin,et al.  Twin study of Parkinson disease , 1981, Neurology.

[620]  R. Marttila,et al.  Smoking and Parkinson's disease , 1980, Acta neurologica Scandinavica.

[621]  E. Granieri,et al.  The risk of Parkinson disease in Mediterranean people , 1980, Neurology.

[622]  T. Elizan,et al.  Search for viral particles and virus‐specific products in idiopathic Parkinson disease brain material , 1979, Annals of neurology.

[623]  M. Yahr,et al.  Viral antibodies in serum and CSF of Parkinsonian patients and controls. , 1979, Archives of neurology.

[624]  E. Granieri,et al.  The frequency of Parkinson's disease in the Province of Nuoro (Sardinia). , 1979, Acta neurologica.

[625]  J. Wetmur,et al.  Nucleic acid homology studies of viral nucleic acids in idiopathic Parkinson's disease. , 1979, Archives of neurology.

[626]  E. Granieri,et al.  Parkinson's disease. Prevalence and incidence in the Province of Sassari, North Sardinia. , 1978, Acta neurologica.

[627]  R. Marttila,et al.  Mortality of patients with parkinson's disease treated with levodopa , 1977, Journal of Neurology.

[628]  J. Mendels,et al.  Psychiatric illness in relatives of patients with Parkinson's disease: a preliminary report. , 1977, The American journal of psychiatry.

[629]  R. Marttila,et al.  Influenza virus antibodies in Parkinsonism. Comparison of postencephalic and idiopathic Parkinson patients and matched controls. , 1977, Archives of neurology.

[630]  R. Marttila,et al.  Arteriosclerosis, heredity, and some previous infections in the etiology of parkinson's disease. A case-control study , 1976, Clinical Neurology and Neurosurgery.

[631]  J. Nagurney,et al.  Essential tremor in Papua, New Guinea. , 1976, Brain : a journal of neurology.

[632]  U. Rinne,et al.  EPIDEMIOLOGY of PARKINSON'S DISEASE IN FINLAND , 1976, Acta neurologica Scandinavica.

[633]  M. Yahr,et al.  Influenza virus antigen in postencephalitic parkinsonism brain. Detection by immunofluorescence. , 1974, Archives of neurology.

[634]  R. M. Paddison,et al.  Occurrence of Parkinson's disease in black patients at Charity Hospital in New Orleans , 1974, Neurology.

[635]  E. Ruoslahti,et al.  Antenatal Diagnosis of Spina Bifida , 1973 .

[636]  Martin We,et al.  Parkinson's disease. A genetic study. , 1973 .

[637]  M. Netsky,et al.  Prevalence of neoplasms and causes of death in paralysis agitans A necropsy study , 1973, Neurology.

[638]  I. I. Kessler,et al.  Epidemiologic studies of Parkinson's disease. II. A hospital-based survey. , 1972, American journal of epidemiology.

[639]  E. Diamond,et al.  Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis. , 1971, American journal of epidemiology.

[640]  M. Nefzger,et al.  A retrospective study of smoking in Parkinson's disease. , 1968, American journal of epidemiology.

[641]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[642]  R. Turnbull,et al.  EPIDEMIOLOGY OF PARKINSONISM IN VICTORIA , 1966, The Medical journal of Australia.

[643]  Rolf Willanger,et al.  METAMORPHOPSIA AND OTHER VISUAL DISTURBANCES WITH LATENCY OCCURRING IN PATIENTS WITH DIFFUSE CEREBRAL LESIONS , 1966 .

[644]  R. Maclennan.  ANTI-VIRUS FOR LEUKAEMIA. , 1964, Lancet.

[645]  R. Schwab,et al.  COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920. , 1963, Journal of chronic diseases.

[646]  R. Duvoisin,et al.  PARKINSONISM BEFORE AND SINCE THE EPIDEMIC OF ENCEPHALITIS LETHARGICA. , 1963, Archives of neurology.

[647]  W. Wegner.  BOXER'S ENCEPHALOPATHY. , 1963, The Journal of sports medicine and physical fitness.

[648]  G. Lacava.  BOXER'S ENCEPHALOPATHY. , 1963, The Journal of sports medicine and physical fitness.

[649]  H. Dorn.  Tobacco consumption and mortality from cancer and other diseases. , 1959, Acta - Unio Internationalis Contra Cancrum.

[650]  K. Westlund,et al.  CANCER AS A CAUSE OF DEATH AMONG PATIENTS WITH OTHER CHRONIC DISEASES , 1956 .

[651]  T. F. Pearse.  The Battle of the Clubs , 1895 .

[652]  S. Jick,et al.  Risk of stroke in patients with idiopathic Parkinson disease. , 2010, Parkinsonism & related disorders.

[653]  M. Farrer,et al.  Reported mutations in GIGYF2 are not a common cause of Parkinson's disease. , 2009, Movement disorders : official journal of the Movement Disorder Society.

[654]  J. Sundquist,et al.  Socioeconomic and occupational groups and Parkinson’s disease: a nationwide study based on hospitalizations in Sweden , 2009, International archives of occupational and environmental health.

[655]  S. Spangenberg,et al.  A nationwide population study of severe head injury and Parkinson's disease. , 2009, Parkinsonism & related disorders.

[656]  H. Checkoway,et al.  Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. , 2009, Parkinsonism & related disorders.

[657]  Nir Giladi,et al.  Smoking and tea consumption delay onset of Parkinson's disease. , 2009, Parkinsonism & related disorders.

[658]  S. Jick,et al.  Use of Statins and the Risk of Parkinson’s Disease , 2008, Drug safety.

[659]  A. Bonnet,et al.  A-SYNUCLEIN GENE DUPLICATION IS PRESENT IN SPORADIC PARKINSON DISEASE. Authors' reply , 2008 .

[660]  J. Sundquist,et al.  Impact of psychiatric disorders on Parkinson's disease , 2008, Journal of neurology.

[661]  W. Longstreth,et al.  Pesticides and risk of Parkinson disease: a population-based case-control study. , 2005, Archives of neurology.

[662]  P. Ragonese,et al.  Long–term survival of Parkinson's disease , 2005, Journal of Neurology.

[663]  C. Yoo,et al.  Occupations and Parkinson's disease: a multi-center case-control study in South Korea. , 2005, Neurotoxicology.

[664]  A. Hofman,et al.  A study of familial aggregation of depression, dementia and Parkinson's disease , 2004, European Journal of Epidemiology.

[665]  C. Olanow,et al.  Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease , 2003, Annals of neurology.

[666]  Daniel J Schaid,et al.  Survival study of Parkinson disease in Olmsted County, Minnesota. , 2003, Archives of neurology.

[667]  Daniel J Schaid,et al.  Risk tables for parkinsonism and Parkinson's disease. , 2002, Journal of clinical epidemiology.

[668]  H. Petrovitch,et al.  Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson’s Disease , 2001, Drugs & aging.

[669]  Mitsuo Takahashi,et al.  A possible role of influenza A virus infection for Parkinson's disease. , 2001, Advances in neurology.

[670]  P. Mcgeer,et al.  Inflammation in Parkinson's disease. , 2001, Advances in neurology.

[671]  A. Hofman,et al.  Prognosis with Parkinson's disease in europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[672]  A. Hofman,et al.  Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[673]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[674]  E. Moro,et al.  Clinical genetic study of familial Parkinson's disease in Italy. , 1999, Advances in neurology.

[675]  K. Marder,et al.  Dietary iron, animal fats, and risk of Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[676]  F. Jiménez-Jiménez,et al.  Premorbid dietetic habits and risk for Parkinson's disease. , 1997, Parkinsonism & related disorders.

[677]  E. Teng,et al.  A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen. , 1996, Archives of neurology.

[678]  K. Nakashima,et al.  Epidemiology of Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years ago. , 1996, Neuroepidemiology.

[679]  I. Rega,et al.  Prevalence of Parkinson's disease in a population of Uruguay. Preliminary results. , 1996, Advances in neurology.

[680]  C. Hertzman,et al.  A case‐control study of Parkinson's disease in a horticultural region of British Columbia , 1994, Movement disorders : official journal of the Movement Disorder Society.

[681]  E. Larson,et al.  Parkinson's disease in Kin-Hu, Kinmen: a community survey by neurologists. , 1994, Neuroepidemiology.

[682]  E. Beghi,et al.  The prevalence of parkinsonism in Italy: An epidemiological survey of the disease in general practice , 1994, Movement disorders : official journal of the Movement Disorder Society.

[683]  G. Grabowski.  Gaucher disease. Enzymology, genetics, and treatment. , 1993, Advances in human genetics.

[684]  K. Watanabe,et al.  Lifestyles, risk factors, and inherited predispositions in Parkinson's disease. Preliminary report of a case-control study. , 1993, Advances in neurology.

[685]  H. Tohgi,et al.  The urate and xanthine concentrations in the cerebrospinal fluid in patients with vascular dementia of the Binswanger type, Alzheimer type dementia, and Parkinson's disease , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[686]  G. Román,et al.  Worldwide occurrence of Parkinson's disease: an updated review. , 1993, Neuroepidemiology.

[687]  C. C. Johnson,et al.  Parkinson's disease mortality and the industrial use of heavy metals in Michigan , 1993, Movement disorders : official journal of the Movement Disorder Society.

[688]  E. Auff,et al.  Physical activity and sports in patients suffering from Parkinson's disease in comparison with healthy seniors , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[689]  M. Hamida,et al.  Prevalence study of neurologic disorders in Kelibia (Tunisia). , 1993, Neuroepidemiology.

[690]  B. Snow,et al.  Criteria for diagnosing Parkinson's disease , 1992, Annals of neurology.

[691]  F. Jiménez-Jiménez,et al.  Exposure to well water and pesticides in Parkinson's disease: A case‐control study in the madrid area , 1992, Movement disorders : official journal of the Movement Disorder Society.

[692]  D. Mateo,et al.  Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case‐control study , 1992, Movement disorders : official journal of the Movement Disorder Society.

[693]  G. Meco,et al.  Mortality rates for Parkinson's disease and parkinsonism in Italy (1969-1987). , 1992, Neuroepidemiology.

[694]  H. Checkoway,et al.  A pilot study of occupational and environmental risk factors for Parkinson's disease. , 1991, Neurotoxicology.

[695]  M. Stern,et al.  Head trauma as a risk factor for Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[696]  W. Weiner,et al.  Prior history of head trauma in Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[697]  S. Moochhala,et al.  Smoking and Parkinson's Disease - A New Perspective , 1991, Reviews on environmental health.

[698]  Ward Cd,et al.  Research diagnostic criteria for Parkinson's disease. , 1990 .

[699]  C. Hertzman,et al.  Parkinson's disease: a case-control study of occupational and environmental risk factors. , 1990, American journal of industrial medicine.

[700]  L. Golbe,et al.  Follow‐up study of early‐life protective and risk factors in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[701]  S. Hodge,et al.  Twin studies and the genetics of Parkinson's disease—a reappraisal , 1990, Movement disorders : official journal of the Movement Disorder Society.

[702]  S. Kobayashi,et al.  Prevalence of Parkinson's disease in Izumo City, Japan. , 1990, Gerontology.

[703]  L. Forsgren,et al.  Community-based study of neurological disorders in rural central Ethiopia. , 1990, Neuroepidemiology.

[704]  A. Hofman,et al.  Incidence and risk factors of Parkinson's disease in The Netherlands. , 1989, Neuroepidemiology.

[705]  K. Meador,et al.  Neuroepidemiology of Parkinson's disease: analysis of mortality data for the U.S.A. and Georgia. , 1989, The International journal of neuroscience.

[706]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[707]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[708]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[709]  J. Dambrosia,et al.  Parkinson's disease in twins. , 1984, Advances in neurology.

[710]  W. Poewe,et al.  Premorbid personality of Parkinson patients. , 1983, Journal of neural transmission. Supplementum.

[711]  D. Black,et al.  Tribute to Professor Michael Gelfand. , 1978, The Central African journal of medicine.

[712]  R. Marttila,et al.  Viral antibodies in the sera from patients with Parkinson disease. , 1977, European neurology.

[713]  H Miller,et al.  Neurological disease in an English city. , 1966, Acta neurologica Scandinavica.

[714]  Kahn Ha.  The Dorn Study of Smoking and Mortality Among U.S. Veterans: Report on Eight and One-Half Years of Observation , 1966 .

[715]  Hammond Ec,et al.  Smoking in relation to the death rates of one million men and women. , 1966 .

[716]  T. Larsson,et al.  Essential tremor: a clinical and genetic population study. , 1960, Acta psychiatrica Scandinavica. Supplementum.

[717]  R. Monie,et al.  Occasional Review , 2022 .

[718]  A. Barbeau,et al.  Le Journal Canadien Des Sciences Neurologiques New Data on the Genetics of Parkinson's Disease , 2022 .

[719]  Honglei Chen,et al.  American Journal of Epidemiology Original Contribution Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (aric) Study , 2022 .

[720]  B. Ritz,et al.  American Journal of Epidemiology Original Contribution Parkinson's Disease and Residential Exposure to Maneb and Paraquat from Agricultural Applications in the Central Valley of California , 2022 .

[721]  A. Wing,et al.  American Journal of Epidemiology Original Contribution Dietary Iron Intake and Risk of Parkinson's Disease , 2022 .

[722]  E. Leof,et al.  The FASEB Journal • Research Communication Imatinib mesylate blocks a non-Smad TGF- � pathway and reduces renal fibrogenesis in vivo , 2022 .